StageBio welcomes Michael C. Cerio as Chief Commercial Officer
Mr. Cerio brings 20 years of experience in the life science space, spanning commercial strategy, marketing, sales, M&A, and technology development. As Chief Commercial Officer, Michael will lead StageBio's sales, marketing, and overarching commercial strategy, and work with the company's leadership to identify new growth opportunities.
Michael was previously President, Pharma Services and Molecular Diagnostics for Biocare Medical, and led the creation and growth of a business unit providing biomarker development and diagnostic testing services to a portfolio of pharmaceutical and biotech partners in the preclinical through late stage trial settings. Prior to Biocare, Michael served as Chief Commercial Officer of Signal Genetics, a publicly traded molecular diagnostics company offering a proprietary gene expression test to inform treatment selection for multiple myeloma patients. His prior experience includes consulting for several leading life science venture capital firms, and the formation of a molecular diagnostics spinout from Moffitt Cancer Center. Michael also led business development and new product licensing for Genzyme Genetics, a leading oncology and prenatal health reference lab, prior to its acquisition by LabCorp.
Michael holds a MBA from Columbia University, with a MS in Molecular and Cellular Biology from the University of Connecticut and a BS in Bioiogy from Syracuse University.
For further information contact:
Director of Corporate Development